医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2013年
22期
91-92
,共2页
胃癌%多西紫杉醇%氟尿嘧啶%化疗
胃癌%多西紫杉醇%氟尿嘧啶%化療
위암%다서자삼순%불뇨밀정%화료
Gastrice cancer%Docetaxel Fluorourat%Chemotherapy
目的比较氟尿嘧啶联合多西紫杉醇与氟尿嘧啶联合顺铂治疗老年晚期胃癌的疗效。方法将71例老年晚期胃癌按随机数字表法分为观察组(n=36)和对照组(n=35),对照组给予顺铂和氟尿嘧啶治疗,观察组给予多西紫杉醇与氟尿嘧啶治疗,治疗2个周期后观察其临床治疗效果和不良反应情况。结果观察组有效率为63.9%,对照组有效率为48.6%,差异具有统计学意义(P<0.05)。与治疗前比较,两组治疗后生活质量评分均有所提高,但是差异无统计学意义(P>0.05)。两组患者主要表现为骨髓抑制和消化道反应,观察组不良反应更少,程度更轻。结论多西紫杉醇联合氟尿嘧啶治疗晚期胃癌有较好疗效,能减缓肿瘤的进展,改善其生存质量,药物毒副作用较轻。
目的比較氟尿嘧啶聯閤多西紫杉醇與氟尿嘧啶聯閤順鉑治療老年晚期胃癌的療效。方法將71例老年晚期胃癌按隨機數字錶法分為觀察組(n=36)和對照組(n=35),對照組給予順鉑和氟尿嘧啶治療,觀察組給予多西紫杉醇與氟尿嘧啶治療,治療2箇週期後觀察其臨床治療效果和不良反應情況。結果觀察組有效率為63.9%,對照組有效率為48.6%,差異具有統計學意義(P<0.05)。與治療前比較,兩組治療後生活質量評分均有所提高,但是差異無統計學意義(P>0.05)。兩組患者主要錶現為骨髓抑製和消化道反應,觀察組不良反應更少,程度更輕。結論多西紫杉醇聯閤氟尿嘧啶治療晚期胃癌有較好療效,能減緩腫瘤的進展,改善其生存質量,藥物毒副作用較輕。
목적비교불뇨밀정연합다서자삼순여불뇨밀정연합순박치료노년만기위암적료효。방법장71례노년만기위암안수궤수자표법분위관찰조(n=36)화대조조(n=35),대조조급여순박화불뇨밀정치료,관찰조급여다서자삼순여불뇨밀정치료,치료2개주기후관찰기림상치료효과화불량반응정황。결과관찰조유효솔위63.9%,대조조유효솔위48.6%,차이구유통계학의의(P<0.05)。여치료전비교,량조치료후생활질량평분균유소제고,단시차이무통계학의의(P>0.05)。량조환자주요표현위골수억제화소화도반응,관찰조불량반응경소,정도경경。결론다서자삼순연합불뇨밀정치료만기위암유교호료효,능감완종류적진전,개선기생존질량,약물독부작용교경。
Objective To evaluate the efficacy and adverse effects of docetaxel combined with 5-fluorouracil in treating patients with advanced gastric cancer. Methods 71 patients with advanced gastric cancer were randomly divided into observation group and control group, observation group treated with docetaxel combined with 5- fluorouracil, the control group treated with 5-fluorouracil and cisplatin, the clinical efficacy after the treatment was observerd. Results The clinical efficiency rate of the observation group was significantly higher than that of the control group, the rate of leukopenia, thrombocytopenia and gastrointestinal reactions of the observation group was significantly lower than the control group, the quality of life scores of the two groups after treatment were al improved, but that of the observation group was significantly higher than the control group, the difference was statistical y significant(P<0.05). Conclusion Docetaxel combined with 5-fluorouracil was effective in treating advanced gastric cancer. It worth further clinical research and application.